Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation Plan First in Human Trial Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy "LOPAIN3"

NCT05732818 is registered in ClinicalTrials.gov with Spinal Stabilization Technologies as lead sponsor.

NCT NCT05732818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05732818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation Plan First in Human Trial Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy "LOPAIN3"
Lead sponsor
Spinal Stabilization Technologies
Phase
Not applicable
Overall status
Suspended
Start date
June 16, 2023
Completion date
June 16, 2027
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, back pain with radiation, disc herniation, disc injury, disk herniated lumbar, herniated disc, herniated nucleus pulposus, radiculopathy